These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3552512

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study).
    Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli MC, Crinò A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Suppa M, Sulli N, De Mattia G, Faldetta MR.
    Eur J Endocrinol; 1997 Sep; 137(3):234-9. PubMed ID: 9330586
    [Abstract] [Full Text] [Related]

  • 6. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr 01; 128(7):517-23. PubMed ID: 9518395
    [Abstract] [Full Text] [Related]

  • 9. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
    Taha DR, Castells S, Umpaichitra V, Bastian W, Banerji MA.
    J Pediatr Endocrinol Metab; 2002 Jan 01; 15(1):59-67. PubMed ID: 11822582
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factors predicting course of beta-cell function in IDDM.
    Schiffrin A, Suissa S, Weitzner G, Poussier P, Lalla D.
    Diabetes Care; 1992 Aug 01; 15(8):997-1001. PubMed ID: 1505333
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
    Miki H, Matsuyama T, Fujii S, Komatsu R, Nishioeda Y, Omae T.
    Diabetes Res Clin Pract; 1992 Nov 01; 18(2):99-105. PubMed ID: 1478158
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
    Böber E, Dündar B, Büyükgebiz A.
    J Pediatr Endocrinol Metab; 2001 Apr 01; 14(4):435-41. PubMed ID: 11327378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.